Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
7.54
0.24 (3.29%)
At close: Aug 15, 2025, 1:06 PM
Xeris Biopharma Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for XERS stock have an median target of 6.25, with a low estimate of 6 and a high estimate of 7. The median target predicts a decrease of -17.11% from the current stock price of 7.54.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 6 | 6.38 | 6.25 | 7 |
| Change | -20.42% | -15.38% | -17.11% | -7.16% |
Latest Analyst Insight Report
Oppenheimer maintains an Outperform rating on Xeri... Unlock content with Pro Subscription
Updated May 09, 2025
| Rating | Aug 24 | Nov 24 | Jan 25 | Mar 25 | May 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 2 | 0 | 0 |
| Buy | 1 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 1 | 0 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 1 | 4 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
280.93M
from 203.07M
Increased by 38.3%
Revenue Next Year
341.03M
from 280.93M
Increased by 21.4%
EPS This Year
-0.04
from -0.37
Increased by 89.2%
EPS Next Year
0.23
from -0.04
Increased by -475%